
Xolair 150mg Injection
Marketer
Novartis India Ltd
Salt Composition
Omalizumab (150mg)
Overview Xolair 150mg Injection
Omalizumab 150mg injection, a targeted antibody therapy, treats moderate-to-severe asthma in adults and children. It alleviates characteristic asthma symptoms including wheezing, shortness of breath, chest tightness, and cough. Administered as an injection, initial doses are given under medical supervision. Your physician will provide self-injection training for home administration. Dosage is individualized to manage your symptoms effectively. Continue treatment as prescribed, even if feeling improved. Commonly reported side effects include arthralgia, generalized pain, tiredness, vertigo, bone fractures, pruritus, skin rash, upper abdominal discomfort, common cold symptoms, cephalalgia, and otalgia. Report any concerning or persistent side effects to your doctor; management strategies may be available. This medication doesn't prevent acute asthma attacks; therefore, always carry your rescue inhaler. Prior to commencing treatment, inform your doctor of any liver or kidney conditions, pregnancy, or pregnancy plans. All other medications should be disclosed, as interactions may impact efficacy or mechanism. Alcohol consumption is generally discouraged during treatment.
Primary Ingredients of Xolair 150mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Xolair 150mg Injection
Bronchial hyperreactivity
Major Benefits of Xolair 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xolair 150mg Injection:
- Joint pain
- Pain
- Fatigue
- Dizziness
- Fracture
- Itching
- Dermatitis
- Upper abdominal pain
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Ear pain
How to use Xolair 150mg Injection:
The medication will be administered by your physician or their assistant; self-medication is strongly discouraged.
How Xolair 150mg Injection works:
Xolair, a 150mg injectable monoclonal antibody, targets immunoglobulin E proteins, key players in the development of asthma.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Xolair 150mg Injection with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The use of 150mg Xolair injections during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data from human studies remain scarce.
Breast feedingCONSULT YOUR DOCTOR
Administering Xolair 150mg Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 150mg Xolair injection.
KidneySAFE IF PRESCRIBED
The use of 150mg Xolair injections in individuals with kidney disease appears to present a low risk. Current evidence indicates that dosage modification for this patient group may be unnecessary. However, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Xolair 150mg Injection in individuals with liver conditions appears to present minimal risk. Current evidence indicates dose modification may be unnecessary for this patient population. However, physician consultation is advised.
What if you forget to take Xolair 150mg Injection :
NA
Facts to Know About Xolair 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Actions | Monoclonal anti-IgE antibodies |
